Characterization of an immune response

Developments in Biologicals

Volumn 122, Issue , 2005, Pages 95-101

  Swanson, S J ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FACTOR; BIOLOGICAL PRODUCT;

ANIMAL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; CONFERENCE PAPER; DRUG SCREENING; HUMAN; IMMUNOASSAY; IMMUNOLOGY; METHODOLOGY; STANDARD;

ANIMALS; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; BIOLOGICAL FACTORS; BIOLOGICAL PRODUCTS; DRUG EVALUATION; HUMANS; IMMUNOASSAY;

EID: 33644618536     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (11)

1. Jönsson U, Fägerstam LG, Ivarsson B, et al: Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques. 1991;11:620-627.
2. Van Regenmortel MH: Use of biosensors to characterize recombinant proteins. Dev Biol Standards. 1994;83:143-151.
3. Malmqvist M, Karlsson R: Biomolecular interaction analysis: affinity biosensor technologies for functional analysis of proteins. Curr Opin Chem Biol 1997;1:378-383.
4. Schuck P: Use of surface plasmon resonance to probe the equilibrium and dynamic aspects of interactions between biological macromolecules. Ann Rev Biophys Biomol Struct: 1997;26:541-566.
5. Takacs MA, Jacobs SJ, Bordens RM, Swanson SJ: Detection and characterization of antibodies to PEG-interferon alfa-2b using surface plasmon resonance. Journal of Interferon and Cytokine Research 1999;19:781-789.
6. Swanson SJ: New technologies for the detection of antibodies to therapeutic proteins, in Brown F, Mire-Sluis AR (eds): Immunogenicity of Therapeutic Biological Products. Dev Biol. Basel, Karer, 2003, vol 112, pp 127-133.
7. Swanson SJ, Mytych D, Ferbas J: Use of biosensors to monitor the immune response, in Brown F, Lubiniecki A, Murano G (eds): Biologies 2000 - Comparability of Biotechnology Products. Dev Biol. Basel, Karger, 2002, vol 109, pp 71-78.
8. Mason S, La S, Mytych D, Swanson SJ, Ferbas J: Validation of the BIACORE 3000 platform for detection of antibodies against erythropoietic agents in human serum samples. Current Medical Research and Opinions. 2003;19(7):651-659.
9. Wong R, Mytych D, Jacobs S, Borden R, Swanson SJ: Validation parameters for a novel biosensor assay which simultaneously measures serum concentrations of a humanized monoclonal antibody and detects induced antibodies. J Immunol Methods 1997;209:1-15.
10. Koren E: From characterization of antibodies to prediction of immunogenicity, in Brown F, Lubiniecki A, Murano G (eds): Biologics 2000 - Comparability of Biotechnology Products. Dev Biol. Basel, Karger, 2002, vol 109, pp 87-95.
11. Casadevall N, Nataf J, Viron B, et al: Pure red cell aplasia and antierythropoetin antibodies in patients treated with recombinant erythropoietin. N Engl J Med. 2002;346:469-475.